Mount Sinai Health System has opened New York City's first eye stroke program to accelerate the diagnosis and treatment of patients who arrive in the emergency room with an eye stroke, a medical emergency that must be treated as soon as possible to avoid

Luminopia has received “de novo premarket” approval by the FDA for Luminopia One as a prescription therapy to improve vision in children with amblyopia (lazy eye), the most common cause of vision loss in children.

Restoring Vision, a leading global nonprofit dedicated to addressing the unmet need for eyeglasses in impoverished communities across the globe, is seeking to help 50,000 people see clearly again by raising $50,000 on Giving Tuesday next week.